Spruce Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Spruce Biosciences, Inc. (SPRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 210.00 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2024-11-12
- Spruce Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 0.00 shares.
- Spruce Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 947.92K shares, a 46.62% decline from fiscal 2020.
- Spruce Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 1.78M shares, a 315.83% increase from fiscal 2019.
- Spruce Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 427.06K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 210.00K shares 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 210.00K shares 10-Q · filed 2024-08-12 | |||
| 2021-12-31 | 947.92K shares 10-K · filed 2022-03-14 | |||
| 2020-12-31 | 1.78M shares 10-K · filed 2022-03-14 | |||
| 2019-12-31 | 427.06K shares 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |